BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21984609)

  • 1. Immunological aspects of 22q11.2 deletion syndrome.
    Gennery AR
    Cell Mol Life Sci; 2012 Jan; 69(1):17-27. PubMed ID: 21984609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes.
    Sullivan KE; Jawad AF; Randall P; Driscoll DA; Emanuel BS; McDonald-McGinn DM; Zackai EH
    Clin Immunol Immunopathol; 1998 Feb; 86(2):141-6. PubMed ID: 9473376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune deficiency of chromosome 22q11.2 deletion syndrome.
    Morsheimer M; Brown Whitehorn TF; Heimall J; Sullivan KE
    Am J Med Genet A; 2017 Sep; 173(9):2366-2372. PubMed ID: 28627729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DiGeorge syndrome/chromosome 22q11.2 deletion syndrome.
    Sullivan KE
    Curr Allergy Asthma Rep; 2001 Sep; 1(5):438-44. PubMed ID: 11892070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome.
    McLean-Tooke A; Spickett GP; Gennery AR
    Scand J Immunol; 2007 Jul; 66(1):1-7. PubMed ID: 17587340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The 22q11.2 deletion syndrome: immunological questions].
    Paśnik J; Cywińska-Bernas A; Piotrowicz M
    Postepy Hig Med Dosw (Online); 2007 Jun; 61():361-8. PubMed ID: 17572656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes).
    Perez E; Sullivan KE
    Curr Opin Pediatr; 2002 Dec; 14(6):678-83. PubMed ID: 12436034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome.
    Gennery AR; Barge D; O'Sullivan JJ; Flood TJ; Abinun M; Cant AJ
    Arch Dis Child; 2002 Jun; 86(6):422-5. PubMed ID: 12023174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome.
    Sullivan KE
    Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):505-12. PubMed ID: 15640691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features and molecular diagnosis of three patients with DiGeorge anomaly].
    Sun JQ; Wang LS; Qi CH; Ying WJ; Guo XH; Liu DR; Hui XY; Liu F; Cao Y; Luo FH; Wang XC
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):944-7. PubMed ID: 23324155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models.
    Bhalla P; Wysocki CA; van Oers NSC
    Front Immunol; 2020; 11():830. PubMed ID: 32431714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for celiac disease in patients with deletion 22q11.2 (DiGeorge/velo-cardio-facial syndrome).
    Digilio MC; Giannotti A; Castro M; Colistro F; Ferretti F; Marino B; Dallapiccola B
    Am J Med Genet A; 2003 Sep; 121A(3):286-8. PubMed ID: 12923874
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).
    Kuo CY; Signer R; Saitta SC
    Curr Allergy Asthma Rep; 2018 Oct; 18(12):75. PubMed ID: 30377837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHARGE syndrome: a review of the immunological aspects.
    Wong MT; Schölvinck EH; Lambeck AJ; van Ravenswaaij-Arts CM
    Eur J Hum Genet; 2015 Nov; 23(11):1451-9. PubMed ID: 25689927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features.
    Jyonouchi S; McDonald-McGinn DM; Bale S; Zackai EH; Sullivan KE
    Pediatrics; 2009 May; 123(5):e871-7. PubMed ID: 19403480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    Smith CA; Driscoll DA; Emanuel BS; McDonald-McGinn DM; Zackai EH; Sullivan KE
    Clin Diagn Lab Immunol; 1998 May; 5(3):415-7. PubMed ID: 9606003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Submicroscopic deletion in chromosome 22q11 in trizygous triplet siblings and their father. Clinical variability of 22q11 deletion.
    Devriendt K; Van Hoestenberghe R; Van Hole C; Devlieger H; Gewillig M; Moerman P; Van den Berghe H; Fryns JP
    Clin Genet; 1997 Apr; 51(4):246-9. PubMed ID: 9184246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome.
    Kanaya Y; Ohga S; Ikeda K; Furuno K; Ohno T; Takada H; Kinukawa N; Hara T
    Clin Exp Immunol; 2006 Apr; 144(1):85-93. PubMed ID: 16542369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple congenital anomalies, thymic dysplasia, severe congenital heart disease, and oligosyndactyly with a deletion of the short arm of chromosome 5.
    Taylor MJ; Josifek K
    Am J Med Genet; 1981; 9(1):5-11. PubMed ID: 6264787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 22q11.2 deletion syndrome and DiGeorge syndrome.
    Sullivan KE
    Immunol Rev; 2019 Jan; 287(1):186-201. PubMed ID: 30565249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.